Chapter 60 Management of Immune Mediated Hemolytic Anemia in Dogs

  1. Day MJ: Antigen specificity in canine autoimmune haemolytic anaemia, Vet Immunol Immunopathol 69:215-224, 1999. PUBMED Abstract
  2. Dudley A et al: Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin, J Vet Intern Med 27:141, 2013. PUBMED Abstract
  3. Duffy AL et al: Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs, Vet Clin Pathol 39:302-305, 2010. PUBMED Abstract
  4. Duval D, Giger U: Vaccine-associated immune-mediated hemolytic anemia in the dog, J Vet Intern Med 10:290-295, 1996. PUBMED Abstract
  5. Holahan ML, Brown AJ, Drobatz KJ: The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006), J Vet Emerg Crit Care 20(4):413, 2010. PUBMED Abstract
  6. Kjelgaard-Hansen M et al: Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs, J Vet Intern Med J Vet Intern Med 25:76-82, 2011. PUBMED Abstract
  7. Lowenberg MC et al: Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands, Steroids 73:1025-1029, 2008.
  8. McManus PM, Craig LE: Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999). J Am Vet Med Assoc 218:1308-1313, 2001. PUBMED Abstract
  9. Mellet AM, Nakamura RK, Bianco D: A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia, J Vet Intern Med 25:71-75, 2011. PUBMED Abstract
  10. Morley P et al: Anti-erythrocyte antibodies and disease associations in anemic and nonanemic dogs, J Vet Intern Med 22:886-892, 2008. PUBMED Abstract
  11. Piek CJ et al: Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs, J Vet Intern Med 22:366-373, 2008. PUBMED Abstract
  12. Piek CJ et al: Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study, BMC Vet Res 7:15, 2011. PUBMED Abstract
  13. Scott KC, Hansen BD, DeFrancesco TC: Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis, J Vet Emerg Crit Care 19:74, 2009. PUBMED Abstract
  14. Scott-Moncrieff C: Immune-mediated hemolytic anemia: 70 cases (1988-1996), J Am Anim Hosp Assoc 37:11, 2001. PUBMED Abstract
  15. Scott-Moncrieff JC et al: Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia, J Am Anim Hosp Assoc 37:220-227, 2001. PUBMED Abstract
  16. Stahn C, Buttgereit F: Genomic and nongenomic effects of glucocorticoids, Nat Clin Pract Rheumatol 4:525-533, 2008. PUBMED Abstract
  17. Weinkle TK et al: Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). J Am Vet Med Assoc 226:1869-1880, 2005. PUBMED Abstract
  18. Weiss DJ, Brazzell JL: Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia, J Vet Intern Med 20:682-686, 2006. PUBMED Abstract
  19. Wells R et al: Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism, J Vet Intern Med 23:295-300, 2009. PUBMED Abstract
  20. Whitley NT, Day MJ: Immunomodulatory drugs and their application to the management of canine immune-mediated disease, J Small Anim Pract 52:70-85, 2011. PUBMED Abstract